Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00247247Phase 4Completed
A Phase 4 trial of entacapone in Parkinson's disease (PD), sponsored by Orion Corporation. Started Dec 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00247247.